학술논문

UNICAB: Cabozantinib in locally advanced or metastatic non‐clear cell renal cell carcinoma post immunotherapy or in those unsuitable for immunotherapy (ANZUP 1802).
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p428-428, 140p
Subject
Language
ISSN
0732183X